Asia Pacific Liposome Drug Delivery Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Liposome Drug Delivery Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Liposome Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Liposome Drug Delivery Market Regional Analysis

6.2 Asia Pacific Liposome Drug Delivery Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Liposome Drug Delivery Market Forecast Analysis

7. Asia Pacific Liposome Drug Delivery Market Analysis – by Product

7.1 Liposomal Doxorubicin

7.1.1 Overview
7.1.2 Liposomal Doxorubicin: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Liposomal Paclitaxel

7.2.1 Overview
7.2.2 Liposomal Paclitaxel: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Liposomal Amphotericin B

7.3.1 Overview
7.3.2 Liposomal Amphotericin B: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Asia Pacific Liposome Drug Delivery Market Analysis – by Technology

8.1 Stealth Liposome Technology

8.1.1 Overview
8.1.2 Stealth Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Non-PEGylated Liposome Technology

8.2.1 Overview
8.2.2 Non-PEGylated Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 DepoFoam Liposome Technology

8.3.1 Overview
8.3.2 DepoFoam Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Lysolipid Thermally Sensitive Liposome Technology

8.4.1 Overview
8.4.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Asia Pacific Liposome Drug Delivery Market Analysis – by Application

9.1 Fungal Diseases

9.1.1 Overview
9.1.2 Fungal Diseases: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Cancer Therapy

9.2.1 Overview
9.2.2 Cancer Therapy: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Pain Management

9.3.1 Overview
9.3.2 Pain Management: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.4 Viral Vaccines

9.4.1 Overview
9.4.2 Viral Vaccines: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.5 Photodynamic Therapy

9.5.1 Overview
9.5.2 Photodynamic Therapy: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Asia Pacific Liposome Drug Delivery Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Liposome Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.2.1.1.2 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.2.1.1.3 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.2.1.2 India: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.2.1.2.2 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.2.1.2.3 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.2.1.3 Japan: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.2.1.3.2 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.2.1.3.3 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.2.1.4 Australia: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.2.1.4.2 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.2.1.4.3 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ASTELLAS PHARMA INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 JOHNSON AND JOHNSON SERVICES, INC.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 LUYE PHARMA GROUP

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Ipsen Pharma

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Gilead Sciences, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Celsion, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Liposome Drug Delivery Market